Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 426

1.

Polysomnographic features of low arousal threshold in overlap syndrome involving obstructive sleep apnea and chronic obstructive pulmonary disease.

Yamaguchi Y, Shiota S, Kusunoki Y, Hamaya H, Ishii M, Kodama Y, Akishita M, Kida K, Takahashi K, Nagase T, Fukuchi Y.

Sleep Breath. 2019 Jan 26. doi: 10.1007/s11325-019-01786-7. [Epub ahead of print]

PMID:
30685846
2.

Borderline pulmonary hypertension associated with chronic hypercapnia in chronic pulmonary disease.

Zuoyou L, Shiota S, Morio Y, Sugiyama A, Sekiya M, Iwakami SI, Ienaga H, Fukuchi Y, Takahashi K.

Respir Physiol Neurobiol. 2019 Apr;262:20-25. doi: 10.1016/j.resp.2019.01.003. Epub 2019 Jan 17.

PMID:
30660859
3.

Society for Translational Medicine expert consensus on the use of antibacterial drugs in thoracic surgery.

Li S, Han Z, He J, Gao S, Liu D, Liu L, He J, Huang Y, Xu S, Mao W, Tan Q, Chen C, Li X, Zhang Z, Jiang G, Xu L, Zhang L, Fu J, Li H, Wang Q, Tan L, Li D, Zhou Q, Fu X, Jiang Z, Chen H, Fang W, Zhang X, Li Y, Tong T, Yu Z, Liu Y, Zhi X, Yan T, Zhang X, Imperatori A, Ibrahim M, Novoa NM, Ng CSH, Petersen RH, Chen JS, Fukuchi Y, Brunelli A, Ismail M, Valverde JA, Rodriguez-Lucas C.

J Thorac Dis. 2018 Nov;10(11):6356-6374. doi: 10.21037/jtd.2018.10.108. Review. No abstract available.

4.

COPD uncovered: a cross-sectional study to assess the socioeconomic burden of COPD in Japan.

Igarashi A, Fukuchi Y, Hirata K, Ichinose M, Nagai A, Nishimura M, Yoshisue H, Ohara K, Gruenberger JB.

Int J Chron Obstruct Pulmon Dis. 2018 Aug 28;13:2629-2641. doi: 10.2147/COPD.S167476. eCollection 2018.

5.

Potential asbestos exposure among patients with primary lung cancer in Japan.

Tamura A, Funakoshi M, J-P NA, Hasegawa K, Ishimine A, Koike A, Tannai N, Fujii M, Hattori M, Hirano H, Nakamura K, Funakoshi M, Satomi K, Yamashita Y, Fukuchi Y, Suganuma N.

J Occup Health. 2018 May 25;60(3):236-245. doi: 10.1539/joh.2017-0199-OA. Epub 2018 Mar 20.

6.

Giant cell arteritis presenting with ANCA-associated glomerulonephritis.

Nakamura G, Fukuchi Y, Homma N.

Clin Exp Nephrol. 2018 Dec;22(6):1439-1441. doi: 10.1007/s10157-018-1561-7. Epub 2018 Mar 14. No abstract available.

PMID:
29542048
7.

Memantine in Japanese patients with moderate to severe Alzheimer's disease: meta-analysis of multiple-index responder analyses.

Okuizumi K, Kamata T, Matsui D, Saito K, Matsumoto T, Fukuchi Y.

Expert Opin Pharmacother. 2018 Apr;19(5):425-430. doi: 10.1080/14656566.2018.1442440. Epub 2018 Mar 6.

PMID:
29448852
8.

Activation of ventral tegmental area dopaminergic neurons reverses pathological allodynia resulting from nerve injury or bone cancer.

Watanabe M, Narita M, Hamada Y, Yamashita A, Tamura H, Ikegami D, Kondo T, Shinzato T, Shimizu T, Fukuchi Y, Muto A, Okano H, Yamanaka A, Tawfik VL, Kuzumaki N, Navratilova E, Porreca F, Narita M.

Mol Pain. 2018 Jan-Dec;14:1744806918756406. doi: 10.1177/1744806918756406. Epub 2018 Jan 22.

9.

Sandwich-Cultured Hepatocytes for Mechanistic Understanding of Hepatic Disposition of Parent Drugs and Metabolites by Transporter-Enzyme Interplay.

Matsunaga N, Fukuchi Y, Imawaka H, Tamai I.

Drug Metab Dispos. 2018 May;46(5):680-691. doi: 10.1124/dmd.117.079236. Epub 2018 Jan 19.

PMID:
29352067
10.

Calcitriol exerts an anti-tumor effect in osteosarcoma by inducing the endoplasmic reticulum stress response.

Shimizu T, Kamel WA, Yamaguchi-Iwai S, Fukuchi Y, Muto A, Saya H.

Cancer Sci. 2017 Sep;108(9):1793-1802. doi: 10.1111/cas.13304. Epub 2017 Jul 16.

11.

Analysis of Nonlinear Pharmacokinetics of a Highly Albumin-Bound Compound: Contribution of Albumin-Mediated Hepatic Uptake Mechanism.

Fukuchi Y, Toshimoto K, Mori T, Kakimoto K, Tobe Y, Sawada T, Asaumi R, Iwata T, Hashimoto Y, Nunoya KI, Imawaka H, Miyauchi S, Sugiyam Y.

J Pharm Sci. 2017 Sep;106(9):2704-2714. doi: 10.1016/j.xphs.2017.04.052. Epub 2017 Apr 30.

PMID:
28465151
12.

Long-term safety and efficacy of combined tiotropium and olodaterol in Japanese patients with chronic obstructive pulmonary disease.

Ichinose M, Kato M, Takizawa A, Sakamoto W, Grönke L, Tetzlaff K, Fukuchi Y.

Respir Investig. 2017 Mar;55(2):121-129. doi: 10.1016/j.resinv.2016.09.004. Epub 2016 Dec 22.

PMID:
28274527
13.

Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: Pooled analysis of SHINE and ARISE.

Asai K, Hirata K, Hashimoto S, Fukuchi Y, Kitawaki T, Ikeda K, Fogel R, Banerji D.

Respir Investig. 2016 Nov;54(6):428-435. doi: 10.1016/j.resinv.2016.06.006. Epub 2016 Aug 24.

PMID:
27886854
14.

Simvastatin-Induced Apoptosis in Osteosarcoma Cells: A Key Role of RhoA-AMPK/p38 MAPK Signaling in Antitumor Activity.

Kamel WA, Sugihara E, Nobusue H, Yamaguchi-Iwai S, Onishi N, Maki K, Fukuchi Y, Matsuo K, Muto A, Saya H, Shimizu T.

Mol Cancer Ther. 2017 Jan;16(1):182-192. doi: 10.1158/1535-7163.MCT-16-0499. Epub 2016 Oct 31.

15.

Bone marrow-derived macrophages distinct from tissue-resident macrophages play a pivotal role in Concanavalin A-induced murine liver injury via CCR9 axis.

Amiya T, Nakamoto N, Chu PS, Teratani T, Nakajima H, Fukuchi Y, Taniki N, Yamaguchi A, Shiba S, Miyake R, Katayama T, Ebinuma H, Kanai T.

Sci Rep. 2016 Oct 11;6:35146. doi: 10.1038/srep35146.

16.

The efficacy and safety of combined tiotropium and olodaterol via the Respimat(®) inhaler in patients with COPD: results from the Japanese sub-population of the Tonado(®) studies.

Ichinose M, Taniguchi H, Takizawa A, Grönke L, Loaiza L, Voß F, Zhao Y, Fukuchi Y.

Int J Chron Obstruct Pulmon Dis. 2016 Aug 29;11:2017-27. doi: 10.2147/COPD.S110389. eCollection 2016.

17.

Prevention of COPD exacerbation by lysozyme: a double-blind, randomized, placebo-controlled study.

Fukuchi Y, Tatsumi K, Inoue H, Sakata Y, Shibata K, Miyagishi H, Marukawa Y, Ichinose M.

Int J Chron Obstruct Pulmon Dis. 2016 Apr 21;11:831-8. doi: 10.2147/COPD.S103105. eCollection 2016.

18.

Pharmacological effects of lysozyme on COPD and bronchial asthma with sputum: A randomized, placebo-controlled, small cohort, cross-over study.

Ohbayashi H, Setoguchi Y, Fukuchi Y, Shibata K, Sakata Y, Arai T.

Pulm Pharmacol Ther. 2016 Apr;37:73-80. doi: 10.1016/j.pupt.2016.03.001. Epub 2016 Mar 4.

PMID:
26952317
19.

Impact of Airflow Limitation on Comorbidities and Postoperative Complications in Patients Undergoing Thoracic Surgery: A Retrospective Observational Study.

Yoshimi K, Oh S, Suzuki K, Kodama Y, Sekiya M, Seyama K, Fukuchi Y.

Ann Thorac Cardiovasc Surg. 2016 Jun 20;22(3):146-52. doi: 10.5761/atcs.oa.15-00301. Epub 2016 Mar 1.

21.

Efficacy and safety of the long-acting β2-agonist olodaterol over 4 weeks in Japanese patients with chronic obstructive pulmonary disease.

Ichinose M, Takizawa A, Izumoto T, Tadayasu Y, Hamilton AL, Kunz C, Fukuchi Y.

Int J Chron Obstruct Pulmon Dis. 2015 Aug 20;10:1673-83. doi: 10.2147/COPD.S86002. eCollection 2015.

22.

Effects of transdermal tulobuterol on dyspnea and respiratory function during exercise in patients with chronic obstructive pulmonary disease.

Ichikawa M, Kodama Y, Yoshimi K, Shiota S, Kotajima M, Nakajyo M, Seyama K, Fukuchi Y, Takahashi K.

J Thorac Dis. 2015 Apr;7(4):687-96. doi: 10.3978/j.issn.2072-1439.2015.04.22.

23.

Practical surrogate marker of pulmonary dysanapsis by simple spirometry: an observational case-control study in primary care.

Shiota S, Ichikawa M, Suzuki K, Fukuchi Y, Takahashi K.

BMC Fam Pract. 2015 Mar 26;16:41. doi: 10.1186/s12875-015-0255-4.

24.

IGF2 preserves osteosarcoma cell survival by creating an autophagic state of dormancy that protects cells against chemotherapeutic stress.

Shimizu T, Sugihara E, Yamaguchi-Iwai S, Tamaki S, Koyama Y, Kamel W, Ueki A, Ishikawa T, Chiyoda T, Osuka S, Onishi N, Ikeda H, Kamei J, Matsuo K, Fukuchi Y, Nagai T, Toguchida J, Toyama Y, Muto A, Saya H.

Cancer Res. 2014 Nov 15;74(22):6531-41. doi: 10.1158/0008-5472.CAN-14-0914. Epub 2014 Oct 1.

25.

Tet2-mutated myeloid progenitors possess aberrant in vitro self-renewal capacity.

Kunimoto H, Fukuchi Y, Sakurai M, Takubo K, Okamoto S, Nakajima H.

Blood. 2014 May 1;123(18):2897-9. doi: 10.1182/blood-2014-01-552471. No abstract available.

26.

Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients.

Sakurai M, Kunimoto H, Watanabe N, Fukuchi Y, Yuasa S, Yamazaki S, Nishimura T, Sadahira K, Fukuda K, Okano H, Nakauchi H, Morita Y, Matsumura I, Kudo K, Ito E, Ebihara Y, Tsuji K, Harada Y, Harada H, Okamoto S, Nakajima H.

Leukemia. 2014 Dec;28(12):2344-54. doi: 10.1038/leu.2014.136. Epub 2014 Apr 15.

PMID:
24732596
27.

Autophagy regulation in pancreatic acinar cells is independent of epidermal growth factor receptor signaling.

Ozaki N, Fukuchi Y, Tomiyoshi SR, Uehara H, Ida S, Wang J, Araki K, Sibilia M, Baba H, Yamamura K, Ohmuraya M.

Biochem Biophys Res Commun. 2014 Mar 28;446(1):224-30. doi: 10.1016/j.bbrc.2014.02.111. Epub 2014 Mar 4.

PMID:
24607897
28.

In situ KPFM imaging of local photovoltaic characteristics of structured organic photovoltaic devices.

Watanabe S, Fukuchi Y, Fukasawa M, Sassa T, Kimoto A, Tajima Y, Uchiyama M, Yamashita T, Matsumoto M, Aoyama T.

ACS Appl Mater Interfaces. 2014 Feb 12;6(3):1481-7. doi: 10.1021/am4038992. Epub 2014 Jan 31.

PMID:
24450927
29.

Vitamin C prevents cigarette smoke-induced pulmonary emphysema in mice and provides pulmonary restoration.

Koike K, Ishigami A, Sato Y, Hirai T, Yuan Y, Kobayashi E, Tobino K, Sato T, Sekiya M, Takahashi K, Fukuchi Y, Maruyama N, Seyama K.

Am J Respir Cell Mol Biol. 2014 Feb;50(2):347-57. doi: 10.1165/rcmb.2013-0121OC.

PMID:
24032444
30.

Budesonide/formoterol via Turbuhaler® versus formoterol via Turbuhaler® in patients with moderate to severe chronic obstructive pulmonary disease: phase III multinational study results.

Fukuchi Y, Samoro R, Fassakhov R, Taniguchi H, Ekelund J, Carlsson LG, Ichinose M.

Respirology. 2013 Jul;18(5):866-73. doi: 10.1111/resp.12090.

PMID:
23551359
31.

Robo4 plays a role in bone marrow homing and mobilization, but is not essential in the long-term repopulating capacity of hematopoietic stem cells.

Goto-Koshino Y, Fukuchi Y, Shibata F, Abe D, Kuroda K, Okamoto S, Kitamura T, Nakajima H.

PLoS One. 2012;7(11):e50849. doi: 10.1371/journal.pone.0050849. Epub 2012 Nov 30.

32.

Assessing efficacy of indacaterol in moderate and severe COPD patients: a 12-week study in an Asian population.

To Y, Kinoshita M, Lee SH, Hang LW, Ichinose M, Fukuchi Y, Kitawaki T, Okino N, Prasad N, Lawrence D, Kramer B.

Respir Med. 2012 Dec;106(12):1715-21. doi: 10.1016/j.rmed.2012.09.002. Epub 2012 Oct 5.

33.

Direct reprogramming of terminally differentiated B cells into erythroid lineage.

Sadahira K, Fukuchi Y, Kunimono H, Sakurai M, Ikeda Y, Okamoto S, Nakajima H.

FEBS Lett. 2012 Oct 19;586(20):3645-52. doi: 10.1016/j.febslet.2012.08.019. Epub 2012 Aug 30.

34.

Pulmonary rehabilitation program including respiratory conditioning for chronic obstructive pulmonary disease (COPD): Improved hyperinflation and expiratory flow during tidal breathing.

Yoshimi K, Ueki J, Seyama K, Takizawa M, Yamaguchi S, Kitahara E, Fukazawa S, Takahama Y, Ichikawa M, Takahashi K, Fukuchi Y.

J Thorac Dis. 2012 Jun 1;4(3):259-64. doi: 10.3978/j.issn.2072-1439.2012.03.17.

35.

Electron donor and acceptor spatial distribution in structured bulk heterojunction photovoltaic devices induced by periodic photopolymerization.

Watanabe S, Fukuchi Y, Fukasawa M, Sassa T, Uchiyama M, Yamashita T, Matsumoto M, Aoyama T.

Langmuir. 2012 Jul 17;28(28):10305-9. doi: 10.1021/la3005618. Epub 2012 Jun 29.

PMID:
22712653
36.

Tet2 disruption leads to enhanced self-renewal and altered differentiation of fetal liver hematopoietic stem cells.

Kunimoto H, Fukuchi Y, Sakurai M, Sadahira K, Ikeda Y, Okamoto S, Nakajima H.

Sci Rep. 2012;2:273. doi: 10.1038/srep00273. Epub 2012 Feb 17.

37.

Transdermal tulobuterol patch, a long-actingβ(2)-agonist.

Tamura G, Ichinose M, Fukuchi Y, Miyamoto T.

Allergol Int. 2012 Jun;61(2):219-29. doi: 10.2332/allergolint.11-RA-0358. Epub 2012 Jan 25. Review.

38.

Efficacy and safety of indacaterol 150 and 300 µg in chronic obstructive pulmonary disease patients from six Asian areas including Japan: a 12-week, placebo-controlled study.

Kinoshita M, Lee SH, Hang LW, Ichinose M, Hosoe M, Okino N, Prasad N, Kramer B, Fukuchi Y; Indacaterol Asian COPD Study Investigators.

Respirology. 2012 Feb;17(2):379-89. doi: 10.1111/j.1440-1843.2011.02107.x.

PMID:
22122202
40.

Efficacy and safety of inhaled formoterol 4.5 and 9 μg twice daily in Japanese and European COPD patients: phase III study results.

Bogdan MA, Aizawa H, Fukuchi Y, Mishima M, Nishimura M, Ichinose M.

BMC Pulm Med. 2011 Nov 15;11:51. doi: 10.1186/1471-2466-11-51.

41.

Respiratory health issues in the Asia-Pacific region: an epilogue.

Ip MS, Fukuchi Y, Berend N.

Respirology. 2012 Jan;17(1):1-2. doi: 10.1111/j.1440-1843.2011.02091.x. No abstract available.

PMID:
22023012
42.

[Retrospective Evaluation of the Effect of Aprepitant for Nausea and Vomiting Induced by Cisplatin Chemotherapy].

Kondo Y, Hirashima T, Sakon M, Kobayashi M, Okamoto N, Sasada S, Suzuki H, Tamiya M, Matsuura Y, Sandou M, Fukuchi Y, Usui N, Shimazu F, Fujita K, Fukushima N.

Gan To Kagaku Ryoho. 2011 Jun;38(6):1049-1053. Japanese. No abstract available.

PMID:
28676598
43.

Efficacy of tiotropium in COPD patients from Asia: a subgroup analysis from the UPLIFT trial.

Fukuchi Y, Fernandez L, Kuo HP, Mahayiddin A, Celli B, Decramer M, Kesten S, Liu D, Tashkin D.

Respirology. 2011 Jul;16(5):825-35. doi: 10.1111/j.1440-1843.2011.01982.x. Erratum in: Respirology. 2011 Nov;16(8):1281.

PMID:
21539680
44.

Two types of C/EBPα mutations play distinct but collaborative roles in leukemogenesis: lessons from clinical data and BMT models.

Kato N, Kitaura J, Doki N, Komeno Y, Watanabe-Okochi N, Togami K, Nakahara F, Oki T, Enomoto Y, Fukuchi Y, Nakajima H, Harada Y, Harada H, Kitamura T.

Blood. 2011 Jan 6;117(1):221-33. doi: 10.1182/blood-2010-02-270181. Epub 2010 Sep 30.

45.

TIMP-3 recruits quiescent hematopoietic stem cells into active cell cycle and expands multipotent progenitor pool.

Nakajima H, Ito M, Smookler DS, Shibata F, Fukuchi Y, Morikawa Y, Ikeda Y, Arai F, Suda T, Khokha R, Kitamura T.

Blood. 2010 Nov 25;116(22):4474-82. doi: 10.1182/blood-2010-01-266528. Epub 2010 Aug 26.

46.

Delayed postprandial metabolism of triglyceride-rich lipoproteins in obese young men compared to lean young men.

Nabeno-Kaeriyama Y, Fukuchi Y, Hayashi S, Kimura T, Tanaka A, Naito M.

Clin Chim Acta. 2010 Nov 11;411(21-22):1694-9. doi: 10.1016/j.cca.2010.07.004. Epub 2010 Jul 16.

PMID:
20621072
47.

Bronchodilator efficacy of single doses of indacaterol in Japanese patients with COPD: A randomised, double-blind, placebo-controlled trial.

Kato M, Makita H, Uemura K, Fukuchi Y, Hosoe M, Emery C, Higgins M, Kramer B.

Allergol Int. 2010 Sep;59(3):285-293. doi: 10.2332/allergolint.10-OA-0173. Epub 2010 Jun 25.

48.

Sustained 24-h efficacy of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patients.

Verkindre C, Fukuchi Y, Flémale A, Takeda A, Overend T, Prasad N, Dolker M.

Respir Med. 2010 Oct;104(10):1482-9. doi: 10.1016/j.rmed.2010.04.006. Epub 2010 Jun 11.

49.

Striking species difference in the contribution of concentrative nucleoside transporter 2 to nucleoside uptake between mouse and rat hepatocytes.

Furihata T, Fukuchi Y, Iikura M, Hashizume M, Miyajima A, Nagai M, Chiba K.

Antimicrob Agents Chemother. 2010 Jul;54(7):3035-8. doi: 10.1128/AAC.00010-10. Epub 2010 Apr 26.

50.

Supplemental Content

Loading ...
Support Center